V. Goldobin

[The molecular mechanisms of platelets activation in patients with cerebrovascular disease].

D. Karelov, O. Sirotkina, T. Vavilova, 2015, Biomeditsinskaia khimiia.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.